O
1.19
0.01 (0.85%)
| Previous Close | 1.18 |
| Open | 1.21 |
| Volume | 2,401,837 |
| Avg. Volume (3M) | 938,447 |
| Market Cap | 62,524,984 |
| Price / Sales | 0.500 |
| Price / Book | 1.22 |
| 52 Weeks Range | |
| Earnings Date | 6 Jan 2025 - 10 Jan 2025 |
| Profit Margin | -122.84% |
| Operating Margin (TTM) | -83.16% |
| Diluted EPS (TTM) | -2.74 |
| Quarterly Revenue Growth (YOY) | -5.60% |
| Total Debt/Equity (MRQ) | 422.57% |
| Current Ratio (MRQ) | 6.49 |
| Operating Cash Flow (TTM) | -124.26 M |
| Levered Free Cash Flow (TTM) | -77.26 M |
| Return on Assets (TTM) | -26.83% |
| Return on Equity (TTM) | -141.02% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Outset Medical, Inc. | Bearish | Bearish |
AIStockmoo Score
-0.3
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.5 |
| Average | -0.25 |
|
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 2.11% |
| % Held by Institutions | 52.16% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| C Worldwide Group Holding A/S | 30 Sep 2024 | 1,000,000 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 15 Nov 2024 | Announcement | Outset Medical to Present at the 2024 Stifel Healthcare Conference |
| 06 Nov 2024 | Announcement | Outset Medical Reports Third Quarter 2024 Financial Results |
| 23 Oct 2024 | Announcement | Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024 |
| 23 Oct 2024 | Announcement | New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |